Coherus Oncology Inc
SWB:8C5
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Coherus Oncology Inc
SWB:8C5
|
US |
|
Agora Inc
F:9AG1
|
US |
|
E
|
Eastern Water Resources Development and Management PCL
SET:EASTW
|
TH |
|
S
|
Southern Cross Media Group Ltd
SWB:6MM
|
AU |
|
C
|
China Oilfield Services Ltd
F:CO9
|
CN |
|
C
|
China Oilfield Services Ltd
OTC:CHOLF
|
CN |
|
S
|
Southern Cross Media Group Ltd
F:6MM
|
AU |
|
C
|
Charter Communications Inc
F:CQD
|
US |
|
Standard BioTools Inc
NASDAQ:LAB
|
US |
|
C
|
China Oilfield Services Ltd
XMUN:CO9
|
CN |
Intrinsic Value
Is 8C5 undervalued or overvalued?
See the intrinsic value estimate for 
Coherus Oncology Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Coherus Oncology Does
Coherus BioSciences makes and sells biosimilar medicines and oncology drugs. Biosimilars are highly similar, lower-cost versions of complex biologic drugs made from living cells. Coherus focuses on products used by doctors, hospitals, clinics, and specialty pharmacies, especially in areas like cancer care and immune-related disease.
- Headquarters
- United States of America US
- Employees
- 147
- IPO date
- Nov 6, 2014
Revenue & Expenses Breakdown
Coherus Oncology Inc
Earnings Waterfall
Coherus Oncology Inc
The intrinsic value for Coherus Oncology Inc (8C5) under the Base Case is hidden EUR.
Compared with the current market price of 1.261 EUR, the stock appears hidden.
